**Core Concept:** Rh D blood group system and Rh antibodies, particularly the Rh isoimmunisation and its effects on the fetus. Rh-negative individuals can develop antibodies against Rh-positive blood, which can cross the placenta and affect the fetus.

**Why the Correct Answer is Right:** The correct answer refers to a situation where fetal affection by Rh antibodies is not an issue. In this scenario, the antibodies do not cross the placenta and cause harm to the fetus. This generally occurs when the mother is Rh-negative and the fetus is Rh-positive or vice versa, as the antibodies do not form due to lack of antigenic mismatch.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because it describes a situation where the fetal affection by Rh antibodies does occur. In this case, the mother is Rh-positive, and the fetus is Rh-positive, leading to the formation of Rh antibodies that cross the placenta and cause Rh isoimmunisation.

B. This option is incorrect because it refers to a situation where fetal affection by Rh antibodies does not occur. In this case, the mother has a high titer of Rh antibodies, but the fetus does not have the antigenic mismatch required for the antibodies to cross the placenta and cause harm.

C. This option is incorrect because it describes a situation where fetal affection by Rh antibodies does not occur. In this case, the mother has a high titer of Rh antibodies, but the fetus does not have the antigenic mismatch required for the antibodies to cross the placenta and cause harm.

D. This option is incorrect as it refers to a situation where fetal affection by Rh antibodies does not occur. In this case, the mother has a low titer of Rh antibodies, insufficient for crossing the placenta and causing harm to the fetus.

**Clinical Pearl:** The proper management of Rh isoimmunisation involves close monitoring of the mother's Rh antibody titer and timely administration of Rh immunoglobulin if needed. This prevents the formation of Rh antibodies in the mother and reduces the risk of Rh disease in future pregnancies.